HIGH-DOSE ETOPOSIDE, CYCLOPHOSPHAMIDE, TOTAL-BODY IRRADIATION (VP CY/TBI) AND ALLOGENEIC BONE-MARROW TRANSPLANT (BMT) FOR PATIENTS WITH RESISTANT ACUTE MYELOID-LEUKEMIA (AML) - A PHASE-I-II TRIAL BY THE NORTH-AMERICAN MARROW TRANSPLANT GROUP/

Citation
Ra. Brown et al., HIGH-DOSE ETOPOSIDE, CYCLOPHOSPHAMIDE, TOTAL-BODY IRRADIATION (VP CY/TBI) AND ALLOGENEIC BONE-MARROW TRANSPLANT (BMT) FOR PATIENTS WITH RESISTANT ACUTE MYELOID-LEUKEMIA (AML) - A PHASE-I-II TRIAL BY THE NORTH-AMERICAN MARROW TRANSPLANT GROUP/, Blood, 82(10), 1993, pp. 10000166-10000166
Citations number
NO
Categorie Soggetti
Hematology
Journal title
BloodACNP
ISSN journal
00064971
Volume
82
Issue
10
Year of publication
1993
Supplement
1
Pages
10000166 - 10000166
Database
ISI
SICI code
0006-4971(1993)82:10<10000166:HECTI(>2.0.ZU;2-O